Literature DB >> 32301606

cGAMP as an Adjuvant in Antiviral Vaccines and Cancer Immunotherapy.

Christopher Ritchie, Lingyin Li.   

Abstract

Entities:  

Year:  2020        PMID： 32301606     DOI： 10.1021/acs.biochem.0c00226

Source DB:  PubMed          Journal:  Biochemistry        ISSN： 0006-2960            Impact factor:   3.162


× No keyword cloud information.
  4 in total

1.  Optimization of whole-cell vaccines with CpG/αOX40/cGAMP to strengthen the anti-tumor response of CD4+ T cells in melanomas.

Authors:  Xuedan Du; Jinting Wu; Ye Zhao; Bin Wang; Xiaobo Ding; Qiuyan Lin; Yingyu Chen; Jinduo Zhao; Lixiao Liu; Xiaolu Mao; Zhen Fang; Chunhong Zhang; Wenfeng Li
Journal:  J Cancer Res Clin Oncol       Date:  2022-06-24       Impact factor: 4.322

2.  Engineered Nanoparticulate Vaccines to Combat Recurring and Pandemic Influenza Threats.

Authors:  Chunhong Dong; Bao-Zhong Wang
Journal:  Adv Nanobiomed Res       Date:  2021-12-07

3.  Targeting Stimulator of Interferon Genes (STING) for the Potential Treatment of Cancer and Infectious Diseases.

Authors:  Robert B Kargbo
Journal:  ACS Med Chem Lett       Date:  2021-02-23       Impact factor: 4.345

Review 4.  Nanoparticle-Based Therapies for Turning Cold Tumors Hot: How to Treat an Immunosuppressive Tumor Microenvironment.

Authors:  Giulio Giustarini; Andrea Pavesi; Giulia Adriani
Journal:  Front Bioeng Biotechnol       Date:  2021-06-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.